Venture

Clark Sullivan

Technologies

Therapeutic

Indication

Central Nervous System Disorders

Developmental Disorders

Cox Biosciences is a phase III drug development company developing a promising therapy for improving communication in children with autism.

 

Cox Biosciences LLC Team:

Clark Sullivan